Literature DB >> 9009297

Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice.

E C Lima1, I Garcia, M H Vicentelli, P Vassalli, P Minoprio.   

Abstract

A possible role for tumor necrosis factor (TNF) alpha during Trypanosoma cruzi infection was explored by using transgenic mice expressing in blood high levels of a soluble TNFR1-FcIgG3 fusion protein, which neutralizes the effects of TNF in vivo. Nontransgenic littermates were used as controls. The transgenic mice showed high susceptibility to T. cruzi infection. Inocula sublethal for control mice resulted in over 80% mortality associated with higher levels of parasites in the blood. In histological sections of the hearts of transgenic mice, large parasitic clusters without inflammatory cell infiltrates around the parasites were seen, while smaller parasitic clusters associated with leukocytes were seen in control mice. No difference in specific antibody response or lymphocyte composition of the spleen was found between transgenic and control mice, although the unresponsiveness of spleen cells to concanavalin A stimulation in vitro, typical of the acute phase of T. cruzi infection, was less pronounced in transgenic mice. Infected transgenic mice produced higher levels of gamma interferon than did control mice. These results confirm that TNF is involved in mechanisms leading to parasite clearance and protection from death in the acute phase of T. cruzi infection. More importantly, the data reveal that TNF is necessary for the establishment of effective tissue inflammation and parasite load control in acute experimental Chagas' disease myocarditis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009297      PMCID: PMC174617          DOI: 10.1128/iai.65.2.457-465.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas' disease.

Authors:  M R d'Imperio Lima; H Eisen; P Minoprio; M Joskowicz; A Coutinho
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

2.  Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.

Authors:  M E Ostensen; D L Thiele; P E Lipsky
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

3.  Mechanisms of myocardial damage in Trypanosoma cruzi infection.

Authors:  Z A Andrade
Journal:  Ciba Found Symp       Date:  1983

4.  Isotype of antibodies responsible for immune lysis in Trypanosoma cruzi infected mice.

Authors:  M M Stefani; H A Takehara; I Mota
Journal:  Immunol Lett       Date:  1983       Impact factor: 3.685

5.  Chagas' disease is attenuated in mice lacking gamma delta T cells.

Authors:  E C Santos Lima; P Minoprio
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Tumour necrosis factor (cachectin) production during experimental Chagas' disease.

Authors:  R L Tarleton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

7.  Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies.

Authors:  P Minoprio; H Eisen; M Joskowicz; P Pereira; A Coutinho
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

8.  Genetic control of responses to Trypanosoma cruzi in mice: multiple genes influencing parasitemia and survival.

Authors:  R Wrightsman; S Krassner; J Watson
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

9.  Very large and isotypically atypical polyclonal plaque-forming cell responses in mice infected with Trypanosoma cruzi.

Authors:  M R D'Imperio Lima; M Joskowicz; A Coutinho; T Kipnis; H Eisen
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.

Authors:  J C Unkeless
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more
  26 in total

1.  Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease.

Authors:  C R Marinho; M R D'Império Lima; M G Grisotto; J M Alvarez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes.

Authors:  E O Olivares Fontt; P De Baetselier; C Heirman; K Thielemans; R Lucas; B Vray
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice.

Authors:  E Castaños-Velez; S Maerlan; L M Osorio; F Aberg; P Biberfeld; A Orn; M E Rottenberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.

Authors:  C Hölscher; G Köhler; U Müller; H Mossmann; G A Schaub; F Brombacher
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.

Authors:  C Truyens; F Torrico; R Lucas; P De Baetselier; W A Buurman; Y Carlier
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Toll-like receptor 2 regulates interleukin-1beta-dependent cardiomyocyte hypertrophy triggered by Trypanosoma cruzi.

Authors:  Christine A Petersen; Katherine A Krumholz; Barbara A Burleigh
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.

Authors:  Jian-Jun Wen; Vandanajay Bhatia; Vsevolod L Popov; Nisha Jain Garg
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes.

Authors:  Xueqing Ba; Shivali Gupta; Mercy Davidson; Nisha Jain Garg
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

9.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

10.  ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract.

Authors:  C E Blue; G K Paterson; A R Kerr; M Bergé; J P Claverys; T J Mitchell
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.